EPCAM and neoplasm: Our study reveals a novel functional region of BAP31, and an intrabody against it inhibits N-glycosylation of EpCAM, activates genes related to cytotoxic autophagy, and inhibits the PI3K-Akt-mTOR pathway, significantly inhibiting tumor proliferation.